Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Quality of life outcomes following surgery for patients with coexistent cervical stenosis and multiple sclerosis.
Tried-and-True Antibiotic May Block Conversion to MS
Steroid-responsive hearing impairment in NMO-IgG/aquaporin-4-antibody-positive neuromyelitis optica.
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis.]
A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Negotiating the radiologically isolated syndrome.
Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis: Recommendations from the International MS Falls Prevention Research Network.
Identifying and addressing unmet therapeutic needs in MS.
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
Identification of tissue-specific cell death using methylation patterns of circulating DNA.
Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.
Using Observational Analysis of Multiple Sclerosis Relapse to Design Outcomes-Based Contracts for Disease-Modifying Drugs: A Feasibility Assessment.
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
Injury to a specific neural pathway detected by Ultra-high-field MRI.
Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene.
Pathologic heterogeneity persists in early active multiple sclerosis lesions.
Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.
Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
Vitamin D supplementation in multiple sclerosis patients in 2012: hype or reality as an adjunctive therapy?
Evoked potential tests in clinical diagnosis.
On the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple Sclerosis.
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction.

Pages